Upstream clopidogrel use and the efficacy and safety of early eptifibatide treatment in patients with acute coronary syndrome: an analysis from the Early Glycoprotein IIb/IIIa Inhibition in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial.

Upstream clopidogrel use and the efficacy and safety of early eptifibatide treatment in patients with acute coronary syndrome: an analysis from the Early Glycoprotein IIb/IIIa Inhibition in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial. Circulation. 2011 Feb 22; 123(7):722-30.

View in: PubMed

subject areas

Acute Coronary Syndrome
Coronary Angiography
Drug Therapy, Combination
Electrocardiography
Hemorrhage
Humans
Middle Aged
Multivariate Analysis
Myocardial Ischemia
Peptides
Platelet Aggregation Inhibitors
Platelet Glycoprotein GPIIb-IIIa Complex
Risk Factors
Ticlopidine
Treatment Outcome

authors with profiles

Robert Harrington